Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR18 vs semaglutide in adult type 2 diabetes mellitus
CTR20232069Phase 2Completed
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Jul 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bofanglutide in type 2 diabetes mellitus (T2DM), sponsored by Gan & Lee Pharmaceuticals. Started Jul 2023; status: completed.
02
Drugs
bofanglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20232069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232069.